Zu Y - Search Results

1

Using an RNA aptamer probe for flow cytometry detection of CD30-expressing lymphoma cells.

Zhang P, Zhao N, Zeng Z, Feng Y, Tung CH, Chang CC, Zu Y. Zhang P, et al. Among authors: zu y. Lab Invest. 2009 Dec;89(12):1423-32. doi: 10.1038/labinvest.2009.113. Epub 2009 Oct 12. Lab Invest. 2009. PMID: 19823169 Free PMC article.

2

Detection of the JAK2(V617F) mutation in myeloproliferative disorders by melting curve analysis using the LightCycler system.

Olsen RJ, Tang Z, Farkas DH, Bernard DW, Zu Y, Chang CC. Olsen RJ, et al. Among authors: zu y. Arch Pathol Lab Med. 2006 Jul;130(7):997-1003. doi: 10.5858/2006-130-997-DOTJMI. Arch Pathol Lab Med. 2006. PMID: 16831057 Free article.

3

Primary central nervous system histiocytic sarcoma with relapse to mediastinum: a case report and review of the literature.

Cao M, Eshoa C, Schultz C, Black J, Zu Y, Chang CC. Cao M, et al. Among authors: zu y. Arch Pathol Lab Med. 2007 Feb;131(2):301-5. doi: 10.5858/2007-131-301-PCNSHS. Arch Pathol Lab Med. 2007. PMID: 17284118 Free article.

4

P38 MAPK inhibition enhancing ATO-induced cytotoxicity against multiple myeloma cells.

Wen J, Cheng HY, Feng Y, Rice L, Liu S, Mo A, Huang J, Zu Y, Ballon DJ, Chang CC. Wen J, et al. Among authors: zu y. Br J Haematol. 2008 Jan;140(2):169-80. doi: 10.1111/j.1365-2141.2007.06895.x. Br J Haematol. 2008. PMID: 18173754 Free article.

5

Acute leukemia immunohistochemistry: a systematic diagnostic approach.

Olsen RJ, Chang CC, Herrick JL, Zu Y, Ehsan A. Olsen RJ, et al. Among authors: zu y. Arch Pathol Lab Med. 2008 Mar;132(3):462-75. doi: 10.5858/2008-132-462-ALIASD. Arch Pathol Lab Med. 2008. PMID: 18318587 Free article. Review.

6

p38 mitogen-activated protein kinase has different degrees of activation in myeloproliferative disorders and myelodysplastic syndromes.

Shahjahan M, Dunphy CH, Ewton A, Zu Y, Monzon FA, Rice L, Chang CC. Shahjahan M, et al. Among authors: zu y. Am J Clin Pathol. 2008 Oct;130(4):635-41. doi: 10.1309/2450EGK3V0XK8D9D. Am J Clin Pathol. 2008. PMID: 18794058

7

Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition.

Wen J, Feng Y, Huang W, Chen H, Liao B, Rice L, Preti HA, Kamble RT, Zu Y, Ballon DJ, Chang CC. Wen J, et al. Among authors: zu y. Leuk Res. 2010 Jan;34(1):85-92. doi: 10.1016/j.leukres.2009.05.024. Epub 2009 Jul 15. Leuk Res. 2010. PMID: 19608275

8

Unique biomechanical interactions between myeloma cells and bone marrow stroma cells.

Feng Y, Ofek G, Choi DS, Wen J, Hu J, Zhao H, Zu Y, Athanasiou KA, Chang CC. Feng Y, et al. Among authors: zu y. Prog Biophys Mol Biol. 2010 Sep;103(1):148-56. doi: 10.1016/j.pbiomolbio.2009.10.004. Epub 2009 Oct 17. Prog Biophys Mol Biol. 2010. PMID: 19840813 Review.

9

Bone marrow stromal cells from myeloma patients support the growth of myeloma stem cells.

Feng Y, Wen J, Mike P, Choi DS, Eshoa C, Shi ZZ, Zu Y, Chang CC. Feng Y, et al. Among authors: zu y. Stem Cells Dev. 2010 Sep;19(9):1289-96. doi: 10.1089/scd.2010.0010. Stem Cells Dev. 2010. PMID: 20121456

10

Synergistic growth inhibition of anaplastic large cell lymphoma cells by combining cellular ALK gene silencing and a low dose of the kinase inhibitor U0126.

Ito M, Zhao N, Zeng Z, Chang CC, Zu Y. Ito M, et al. Among authors: zu y. Cancer Gene Ther. 2010 Sep;17(9):633-44. doi: 10.1038/cgt.2010.20. Epub 2010 May 7. Cancer Gene Ther. 2010. PMID: 20448669 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

917 results

Search Page

Filters